




















![]()
Q1: 2026-05-06 Earnings Summary
EPS of $2.07 beats by $0.97
|
Revenue of
$4.65B
(52.55% Y/Y)
misses by $269.78M
Oscar Health, Inc. (OSCR) Q1 2026 Earnings Call May 6, 2026 8:00 AM EDT
Company Participants
Chris Potochar - Vice President of Treasury & Investor Relations
Mark Bertolini - CEO & Director
Richard Blackley - Chief Financial Officer
Conference Call Participants
Jessica Tassan - Piper Sandler & Co., Research Division
John Ransom - Raymond James & Associates, Inc., Research Division
Andrew Mok - Barclays Bank PLC, Research Division
Samuel Becker - Goldman Sachs Group, Inc., Research Division
Jonathan Yong - UBS Investment Bank, Research Division
Olivia Miles - Robert W. Baird & Co. Incorporated, Research Division
Raj Kumar - Stephens Inc., Research Division
Craig Jones - BofA Securities, Research Division
Dillon Nissan - Wolfe Research, LLC
Presentation
Operator
Good morning. My name is Jeannie, and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health's First Quarter 2026 Earnings Conference Call. [Operator Instructions]
I will now turn the conference over to Chris Potochar, Vice President of Treasury and Investor Relations.
Chris Potochar
Vice President of Treasury & Investor Relations
Good morning, everyone. Thank you for joining us for our first quarter 2026 earnings call. Mark Bertolini, Oscar Health's Chief Executive Officer; and Scott Blackley, Oscar Health's Chief Financial Officer, will host this morning's call. This call can also be accessed through our Investor Relations website at ir.hioscar.com. Full details of our results and additional management commentary are available in our earnings release, which can be found on our Investor Relations website at ir.hioscar.com.
Any remarks that Oscar makes about the future constitute forward-looking statements within the meaning of safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our annual report on Form 10-K for the
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。